Gia Lai to standardize Ngoc Linh ginseng value

In April, Truong Sinh Group, in collaboration with Truong Nhan Pharma, held the event "The journey of Viet Nam’s national treasure ginseng and standardization of Vietnamese medicinal herbs."

This marks the official launch of a large-scale medicinal herb development project for the 2026-2030 period, aimed at building a sustainably standardized value chain, from cultivation areas and factories to testing, products, and consumer experience.

Ngoc Linh ginseng is developed not only as a precious ingredient, but as the core of a medicinal ecosystem linked to high-tech processing, healthcare, local promotion, and experiential tourism.

Mr. Phan Thanh Thien, CEO of Truong Sinh Group, said the company is focusing on a sustainable development strategy for Ngoc Linh ginseng, from expanding cultivation areas to securing raw material supply. The company currently manages 70 hectares with more than 500,000 ginseng plants. It aims to increase this to 1 million plants by 2026 and 2 million by 2028. At the same time, it is accelerating deep processing and building a “Ginseng - Medicinal herbs - Healthcare” ecosystem based on four pillars: expanding cultivation areas, promoting deep processing, integrating tourism and healthcare, and expanding a nationwide distribution network.

A highlight of the project is the “Five standards for Vietnamese ginseng” framework initiated by Truong Sinh Group, including standards for plant varieties, cultivation and care conditions, processing procedures, testing protocols, and branding and sales channels.

Through this framework, Truong Sinh Group aims to move beyond the conventional perception of Vietnamese ginseng as merely “rare, precious, and expensive,” toward a model grounded in proper practices, standardization, and verification.

To standardize the value of Ngoc Linh ginseng, Truong Sinh Group has signed a strategic partnership with Pharmacity to bring its products into more than 1,000 pharmacies nationwide, thereby expanding distribution channels for Vietnamese medicinal products.

“We believe that the sustainable value of medicinal herbs begins at the cultivation stage, with production standards, processing technology, and long-term development strategies. Truong Sinh Group hopes to help build renewed trust in Vietnamese medicinal products and gradually elevate Ngoc Linh ginseng into a national medicinal symbol,” Mr. Thien shared.

Meanwhile, Truong Nhan Pharma is developing products derived from Ngoc Linh ginseng on e-commerce platforms. According to Ms. Hoang Minh Hanh, a representative of Truong Nhân Pharma, the company aims to make Ngoc Linh ginseng a familiar product in the daily lives of Vietnamese people, particularly through online sales channels.

“Vietnamese ginseng is not only a ‘national treasure’ in name, but will truly become part of every Vietnamese family’s health care journey,” Ms. Hanh shared.

Mr. Nguyen Thien Duc, Director of Legal and Compliance for product categories at Pharmacity, said that Pharmacity not only provides authentic products but also strategically invests in activities that raise public awareness of sustainable healthcare.

“Cooperating with Truong Sinh Group to develop Ngoc Linh ginseng products will help deliver effective healthcare solutions, enabling communities to take a more proactive role in protecting and improving their health,” Mr. Duc noted.